April M Weissmiller is an Assistant Professor at Middle Tennessee State University. She obtained a B.S. at San Diego State University in 2007 and her Ph.D. at the University of California, San Diego, in 2013. She has received numerous awards, such as the Rally Foundation for Childhood Cancer Research Young Investigator Award, the Rally Foundation for Childhood Cancer Research and Open Hands Overflowing Hearts Co-funded fellowship award, and the AACR Basic Cancer Research fellowship award.

Stephen W Fesik is a Professor in the Department of Biochemistry at Vanderbilt University School of Medicine, where he leads a group focused on cancer drug discovery. He is also a member of the Vanderbilt-Ingram Cancer Center, the Institute of Chemical Biology, and the Center for Structural Biology. He earned his Ph.D. in Medicinal Chemistry from the University of Connecticut and was a Post-Doctoral Associate at Yale University in the Department of Molecular Biophysics and Biochemistry. Before joining Vanderbilt, he was Divisional Vice President of Cancer Research at Abbott Laboratories, where he led a group responsible for discovering new drugs to treat cancer. He has been a reviewer for the NIH Biophysical Chemistry Study Section. He has 290 publications with 40015 citations and an h-index of 94 (Scopus, 7 December 2023).

William P Tansey received his Ph.D. from the University of Sydney in 1991. He performed his postdoctoral studies at Cold Spring Harbor in New York and stayed on there as faculty until 2009 when he moved to Vanderbilt University. He is currently a Professor of Cell and Developmental Biology, holds a secondary appointment in the Department of Biochemistry and is an Ingram Professor of Cancer Research. He is a Co-Leader of the Genome Maintenance Research Program/VICC. He has 96 publications with 6601 citations and an h-index of 37 (Scopus, 6 December 2023).